Catch up on the top radiology content of the past week.
News|Slideshows|September 20, 2026
Radiology Roundup of FDA News: September 13 — September 19
Author(s)Diagnostic Imaging Staff
Catch up on a variety of FDA news in radiology from the past week.
Advertisement
From the newly FDA-approved PET agent floretyrosine F18 for glioma imaging and a foundation model-based chest X-ray AI software to MRI-guided enhancement of PET neuroimaging, here are key FDA news developments in radiology from the past week.
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
Catch up on the most-well viewed radiology content in August 2026.
Catch up on the top AI-related news and research in radiology over the past month.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Incorporating structural MRI to improve PET imaging resolution, the MICSI-PET software also offers automated Centiloid quantification from amyloid PET scans.
New research demonstrates significantly higher specificity and inter-reader agreement with MRI-guided reconstruction in comparison to standard ordered-subset expectation-maximization (OSEM) reconstruction of PET imaging for amyloid assessment.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET
2
Diagnostic Imaging’s Weekly Scan: September 13 — September 19
3
Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod
4
Radiology Roundup of FDA News: September 13 — September 19
5